Alector Investors
Alector is an innovative angel investment group based in San Francisco, California, founded in 2013 The organization focuses on advancing biotechnology and therapeutic solutions to address neurodegenerative diseases With a significant investment scale of $176,000,000, Alector is dedicated to supporting early-stage companies that demonstrate potential for impactful breakthroughs in healthcare The group combines expertise in science and business to foster the development of transformative therapies Alectors commitment to innovation positions it as a key player in the biotechnology investment landscape
Investors
Founded Date:
2013
Last Funding Type:
Series E
Headquarters:
USA
Investors Number:
20
Employee Number:
101-250
Industry:
FemTech
Estimated Revenue:
$10M to $50M
Last Funding Date:
2018-07-25
Number Of Exists:
101-250
Funding Status:
IPO
Investor Type:
Angel Groups
Total Funding:
194500000